Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

被引：0

作者：

Frangoul, Haydar ^{[1
]}

Locatelli, Franco ^{[2
]}

Corbacioglu, Selim ^{[3
]}

De La Fuente, Josu ^{[4
]}

Wall, Donna ^{[5
]}

Cappellini, Maria Domenica ^{[6
]}

de Montalembert, Mariane ^{[7
]}

Kattamis, Antonis ^{[8
]}

Lobitz, Stephan ^{[9
]}

Rondelli, Damiano ^{[10
]}

Sheth, Sujit ^{[11
]}

Steinberg, Martin ^{[12
]}

Walters, Mark ^{[13
]}

Bobruff, Yael ^{[14
]}

Simard, Chris ^{[14
]}

Song, Yang ^{[14
]}

Zhang, Lanju ^{[14
]}

Sharma, Anjali ^{[15
]}

Imren, Suzan ^{[14
]}

Hobbs, Bill ^{[14
]}

Grupp, Stephan A. ^{[16
]}

机构：

[1] Childrens Hosp TriStar Centennial, Nashville, TN USA

[2] Uni Rome, Rome, Italy

[3] Uni Regensburg, Regensburg, Germany

[4] Imperial Coll London, St Albans, England

[5] Hosp Sick Children, Toronto, ON, Canada

[6] Uni Milan, Milan, Italy

[7] Uni Paris, Paris, France

[8] Uni Athens, Athens, Greece

[9] Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany

[10] Uni Ill Chicago, Chicago, IL USA

[11] Weill Cornell Med, New York, NY USA

[12] BU Sch Med, Boston, MA USA

[13] UCSF Benioff Childrens Hosp, Oakland, CA USA

[14] Vertex Pharmaceut, Boston, MA USA

[15] CRISPR Therapeut, Cambridge, MA USA

[16] Uni Penn, Perelman Sch Med, Philadelphia, PA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：1 / 1

页数：1

共 50 条

[41] BETIBEGLOGENE AUTOTEMCEL (BETI-CEL) GENE THERAPY FOR THE TREATMENT OF TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): UPDATED LONG-TERM EFFICACY AND SAFETY RESULTS [J].

Locatelli, F. ;

Yannaki, E. ;

Kwiatkowski, J. L. ;

Walters, M. C. ;

Porter, J. B. ;

Hongeng, S. ;

Kulozik, A. E. ;

Sauer, M. G. ;

Thrasher, A. J. ;

Thuret, I. ;

Lal, A. ;

Cavazzana, M. ;

Du, Lin ;

Colvin, R. A. ;

Rasko, J. E. J. ;

Algeri, M. ;

Thompson, A. A. .

HAEMATOLOGICA, 2021, 106 (10) :7-8

[42] Betibeglogene autotemcel (beti-cel) gene therapy for the treatment of Transfusion-Dependent β-Thalassemia (TDT): Updated long-term efficacy and safety results [J].

Kulozik, A. E. ;

Thuret, I ;

Thompson, A. A. ;

Kwiatkowski, J. L. ;

Porter, J. B. ;

Hongeng, S. ;

Yannaki, E. ;

Sauer, M. G. ;

Thrasher, A. J. ;

Lal, A. ;

Du, L. ;

Colvin, R. A. ;

Walters, M. C. ;

Locatelli, F. .

ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 :8-9

[43] Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience [J].

Ersoy, Gizem Zengin ;

Aycicek, Ali ;

Al, Isik Odaman ;

Bayram, Cengiz ;

Arslantas, Esra ;

Ozdemir, Gul Nihal ;

Uysalol, Ezgi Pasli ;

Salcioglu, Zafer ;

Akici, Ferhan ;

Aydogan, Gonul .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (06) :555-563

[44] Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life [J].

Bhattacharjee, Sukrita ;

Ghosh, Shouriyo ;

Shaw, Jyoti ;

Bhattacharjee, Sunistha ;

Bhattacharyya, Maitreyee .

HEMOGLOBIN, 2024, 48 (03) :161-168

[45] Prevalence and Significance of Pancreatic Iron in Transfusion-Dependent Sickle Cell Disease [J].

Vadivelan, Akhila ;

Doyle, Eamon ;

Carson, Susan ;

Denton, Christopher ;

Veluswamy, Saranya ;

Hofstra, Thomas ;

Coates, Thomas ;

Wood, John C. .

PEDIATRIC BLOOD & CANCER, 2025, 72 (08)

[46] EU Approval for first CRISPR/Cas9 Gene-editing based Therapy Exagamglogenic autotemcel for the Treatment of Sickle Cell Disease and transfusion-dependent Beta-Thalassemia [J].

Ruedesheim, Sabine M. .

TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (02) :127-127

[47] Significant pituitary siderosis is common in transfusion-dependent sickle cell disease [J].

Vadivelan, Akhila ;

Doyle, Eamon K. ;

Carson, Susan ;

Denton, Christopher ;

Veluswamy, Saranya ;

Hofstra, Thomas ;

Coates, Thomas D. ;

Wood, John .

BLOOD, 2024, 144 (13) :1457-1459

[48] EU Approval for first CRISPR/Cas9 Gene-Editing based Therapy Exagamgiogenic Autotemcel for the Treatment of Sickle Cell Disease and transfusion-dependent Beta-Thalassemia [J].

不详 .

ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) :162-162

[49] Severe bacterial infection in transfusion-dependent patients with thalassemia major [J].

Wang, SC ;

Lin, KH ;

Chern, JPS ;

Lu, MY ;

Jou, ST ;

Lin, DT ;

Lin, KS .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (07) :984-988

[50] Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia [J].

Handattu, Koushik ;

Aroor, Shrikiran ;

Kini, Pushpa ;

Ramesh Bhat, Y. ;

Shivakumar, Gayathri ;

Shastry, Praveen ;

Shetty, Sahana .

INDIAN PEDIATRICS, 2022, 59 (12) :920-923

← 1 2 3 4 5 →